Investing Ideas
/
Indonesian Pharmaceuticals & Biotech Too Big To Fail

Indonesian Pharmaceuticals & Biotech Too Big To Fail

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Large established companies which pay a dividend.

1 companies

Kalbe Farma

Market Cap: Rp54.0t

PT Kalbe Farma Tbk., junto con sus filiales, desarrolla, fabrica y comercializa productos farmacéuticos en Indonesia.

KLBF

Rp1,190.00

4.4%

-30.2%